Printer Friendly

Inergetics Inc and The Podiatree Company partnership unveils Intrinsix in support of healthy nerve function and foot health.

M2 PHARMA-December 4, 2013-Inergetics Inc and The Podiatree Company partnership unveils Intrinsix in support of healthy nerve function and foot health


Nutritional supplements company Inergetics Inc (Other OTC:NRTI) announced on Tuesday the availability of Intrinsix, which is the only podiatry-exclusive nerve health support supplement enriched with calcium and vitamin D, in partnership with The Podiatree Company, a provider of podiatry pharmaceuticals.

Inergetics, which has reportedly been developed alongside pharmacist, Robert Graci, R.Ph., has created a unique formula to support healthy nerve function and specifically help diabetic patients who experience nerve-related symptoms in their extremities, which include tingling, pain, burning and loss of sensation, said the company.

According to the company, Intrinsix contains a unique pharmacist-formulated blend of alpha lipoic acid, benfotiamine, calcium, and vitamins B6, B12 and D. The formula is safe for patients with strict dietary restrictions, including vegetarians and those with sugar-free, sodium-free and starch-free diets.

In addition, Intrinsix has been distributed for sale to local podiatrists across the US and will be available immediately to their patients, concluded the company.

((Comments on this story may be sent to

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Dec 4, 2013
Previous Article:Teva Pharmaceutical Industries Ltd partners with Takeda Pharmaceutical Company Limited for glatiramer acetate for treating multiple sclerosis in...
Next Article:Biohit to distribute Dynex's ELISA processing systems with GastroPanel.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters